Previous studies reported higher expression of RFC2 in various tumor tissues, such as glioblastoma25, hepatocellular carcinoma26, nasopharyngeal carcinoma27, and colorectal cancer28, than in normal tissues. The gene discussed is RFC2; the disease is neoplasm.